Finance

Lists
Why is DVA up 2.27%?
Dive Deeper
DVA:NYSE
Davita Inc
$180.82
+2.27%
(+4.01) 1D
Oct 22, 12:11:14 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DVA...
Open
$176.89
High
$180.82
Low
$176.38
Mkt. cap
11.54B
Avg. vol.
702.32K
Volume
199.66K
P/E ratio
14.81
52-wk high
$247.49
52-wk low
$101.00
EPS
$12.21
Beta
0.80
Shares outstanding
63.80M
No. of employees
78K
Open
$176.89
High
$180.82
Low
$176.38
Mkt. cap
11.54B
Avg. vol.
702.32K
Volume
199.66K
P/E ratio
14.81
52-wk high
$247.49
52-wk low
$101.00
EPS
$12.21
Beta
0.80
Shares outstanding
63.80M
No. of employees
78K
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc
CEOJavier J. Rodriguez
Employees78K
Founded1992
HeadquartersDenver, Colorado, United States
SectorHealth care provider
Websitedavita.com
Analyst ratings
Based on 5 analysts giving stock ratings to DVA in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for DVA in the last 3 months.
Highest
Current $180.82
$265.00 (+46.55%)
Average
$231.00 (+27.75%)
Lowest
$215.00 (+18.90%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Maintained
$220.00
+21.7%
10/21/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$224.00
+23.9%
10/21/2026
David S Macdonald
Truist Financial
Hold
Maintained
$215.00
+18.9%
08/11/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
$265.00
+46.6%
08/05/2026
Kevin Fischbeck
Bank of America Securities
Sell
Reiterated
-
-
08/05/2026
A.J. Rice
UBS
Buy
Reiterated
$270.00
+49.3%
07/10/2026
Next call in 7 days
Thu, Oct 29, 11:00 PM
Fiscal period
Q3 2026
- / $3.57
Revenue / Est. (USD)
- / 3.51B
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.42B
3.62B
3.42B
3.55B
Cost of goods sold
2.33B
2.41B
2.34B
2.39B
Cost of revenue
2.33B
2.41B
2.34B
2.39B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402.67M
472.36M
421.91M
423.46M
Operating expense
580.16M
659.06M
599.74M
591.27M
Total operating expenses
2.91B
3.07B
2.94B
2.98B
Operating income
507.30M
551.20M
473.55M
570.82M
Other non operating income
-17.26M
-21.03M
639.00K
4.47M
EBT including unusual items
308.80M
382.76M
341.23M
435.01M
EBT excluding unusual items
351.55M
391.79M
341.23M
437.04M
Income tax expense
68.55M
76.73M
66.20M
91.79M
Effective tax rate
22.20%
20.05%
19.40%
21.10%
Other operating expenses
-
-
-
-
Net income
150.33M
234.22M
197.53M
265.40M
Net profit margin
4.40%
6.47%
5.78%
7.47%
Earnings per share
2.51
3.40
2.87
4.02
Interest and investment income
-
-
-
-
Interest expense
-148.66M
-148.25M
-141.30M
-146.42M
Net interest expenses
-148.66M
-148.25M
-141.30M
-146.42M
Depreciation and amortization charges
177.49M
186.70M
177.83M
167.81M
EBITDA
684.80M
737.91M
651.38M
738.62M
Gain or loss from assets sale
-
-17.55M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps